Table 1. Metaregression of weight changes per period.
Period | aripiprazole | asenapine | clozapine | FGA | haloperidol | olanzapine | quetiapine | risperidone | ziprasidone | placebo |
≤6 wk* | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
6–16 wk | −0.46 −1.78–0.85 | −2.37 −6.93–2.19 | −2.19 −6.63–2.25 | −0.25 −2.50–1.99 | 0.472 −0.16–1.60 | 0.05 −1.26–1.36 | −0.58 −1.57–0.72 | −0.97 −3.08–1.13 | 0.25 −0.14–0.64 | |
16–38 wk | −1.43 −2.75–−0.12 | −1.25 −5.98–3.48 | −3.81 −8.18–0.55 | 2.75 −0.58–6.08 | 0.26−0.68–1.20 | −0.54−1.94–0.86 | −0,03 −1.03–0.96 | −1.68 −3.78–0.41 | −0.26 −0.81–0.28 | |
>38 wk | −0.20 −1.64–1.24 | 0.74 −3.24–4.72 | 1.09 −3.47–5.66 | 2.79 −1.12–6.70 | 1.81 −0.53–4.15 | 1.74 0.50–2.99 | −0.85 −2.56–0.87 | 0.37 −0.63–1.38 | −0.50 −3.67–2.68 | −1.08 −1.88–−0.29 |
The coeffecient indicates the changes of weight compared with the constant (period 1).
* period 1 (≤6 wk) is the reference category.
Data in italics indicate 95% confidence interval.
The data in bold indicate significant difference in weight change of reference category.